The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation

BACKGROUND: Refinement of parameters defining prostate cancer (PC) prognosis are urgently needed to identify patients with indolent versus aggressive disease. The Canadian Prostate Cancer Biomaker Network (CPCBN) consists of researchers from four Canadian provinces to create a validation cohort to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouellet, Véronique, Aprikian, Armen, Bergeron, Alain, Brimo, Fadi, Bristow, Robert G., Chevalier, Simone, Drachenberg, Darrel, Fazli, Ladan, Fleshner, Neil E., Gleave, Martin, Karakiewicz, Pierre, Klotz, Laurence, Lacombe, Louis, Lattouf, Jean-Baptiste, van der Kwast, Theodorus, Squire, Jeremy A., Latour, Mathieu, Trudel, Dominique, Mes-Masson, Anne-Marie, Saad, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131811/
https://www.ncbi.nlm.nih.gov/pubmed/30200929
http://dx.doi.org/10.1186/s12894-018-0392-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131811/
https://www.ncbi.nlm.nih.gov/pubmed/30200929
http://dx.doi.org/10.1186/s12894-018-0392-x

Ejemplares similares